Compare peptides
Put two entries side by side — evidence, mechanism, risks, and community claims.
CJC-1295
Limited
Research chemical
Summary
GHRH analog that stimulates natural growth-hormone pulses; used with GHRPs for body composition and recovery goals.
Categories
Growth Hormone Axis, Performance, Longevity
Mechanism
Binds GHRH receptors on pituitary somatotrophs, increasing GH secretion. With DAC, albumin binding extends half-life; without DAC, effects are short and better timed with sleep or training.
Half-life
No DAC: ~30 minutes; With DAC: multi-day
Routes
Subcutaneous injection
Legal / access
Not FDA-approved. Related GHRH analogs have clinical history, but CJC-1295 research products are typically unapproved.
Key risks
- Water retention
- Tingling / numbness
- Increased hunger (more with some GHRPs)
- Possible IGF-1 elevation concerns long-term
Common claims
- Improved sleep depth and recovery
- Lean mass support and fat-loss synergy
- Skin, hair, and joint quality via elevated GH/IGF-1
Select peptide B